Google TrendMICHAEL OLISE (500+) — Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "A cerebrospinal fluid syn" (30 stories)

Top Headline Story

AC immune reports week-100 progress in VacSyn trial
Lead StoryPharmaTimesworld
Sep 29

AC immune reports week-100 progress in VacSyn trial

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxQeVRQWVJxSWNsREppbWs5bl9IVlFEdnRrY0t3UTFKcVJWQkliMFdOTXE4QW9jQW5tdlJYYXBuN0xlVGlQcW5Hbkl2SVFKVjltRjlNMDg5ZlBCZ2t5bTVkT0htaE9mbGRFVS0xOC0yWnRHMGpCYml3aGlQNW1temV4aF93RU1Eenkw?oc=5" target="_blank">AC immune reports week-100 progress in VacSyn trial</a>  <font color="#6f6f6f">PharmaTimes</font>

Real-time search volume
500+20m ago

michael olise

Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay

1000+20m ago

bank of america fine

Bank of America fined $1.2 billion over money-laundering violations

200+20m ago

club brugge

LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker

200+20m ago

rb leipzig

Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber

Search Results for "A cerebrospinal fluid syn"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104
GlobeNewswireworld

AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104

<a href="https://news.google.com/rss/articles/CBMiigJBVV95cUxNSDJVWjJ3SXV5YlhWVGkyZlMzNzMybHh5YnJOd2xiLWY5V1VCYlBDcWVNd19ObGJZRnZvUXY2WUY4eUZiY2hfWE42SWliWnJWTTdKYlI0OGNQNDh5R1VEVWNoOVBTWXhJQ21mS0dtYnZuZlZqTlhrSTFuUFBKZ2Uya1JISXRXYm5XNGdkaFZkZ0VtNmsyXzZiRzNwSG1hVUVnT0dqRHg3XzlQZ3JrNEJYXzViTlNxcHcxUDhtdFBDemRaRVhTeFRQajdrcmhVTHU2ck1UakxkSzZlQnN3MHAxVGtEdzFLb0o3eS0xOWdvekg4cWNBY1pkY2M3TU9fREVIWEpvYUNjRzZ6QQ?oc=5" target="_blank">AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104</a>  <font color="#6f6f6f">GlobeNewswire</font>

Perivascular spread of CSF-derived α-synuclein oligomers drives region-specific Parkinson’s-like pathology
Naturegeneral

Perivascular spread of CSF-derived α-synuclein oligomers drives region-specific Parkinson’s-like pathology

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAwdlY4OHNDWkhPcGR5UTlGYmphVFpiaGZmRTY2bEpLUl9ESmhTdkdmYW1IWkdHSkcyQVZrZmFMNmNkR0p6OWRGZWdEUzVqUU1kaWYxc09Qblo3SlpkcmQ4?oc=5" target="_blank">Perivascular spread of CSF-derived α-synuclein oligomers drives region-specific Parkinson’s-like pathology</a>  <font color="#6f6f6f">Nature</font>

After 100 weeks, AC Immune's Parkinson's trial met its main safety and immune-response goals.
Stock Titantech

After 100 weeks, AC Immune's Parkinson's trial met its main safety and immune-response goals.

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPUHp2NWdfSUw4MTVRNk41NG9abDU0RGhFdk5hNEdxRTQ5NTV6b3dZeUNlMFN4Vk94LUQ1MWxMbXVqX3llMmZfdEdZQ2d1MktZU0ZHdnhaSEZ5YWNTUmlfQm1wT2NxTU01WUlHX3ZXSDN0ODdOWVN4d1lucUF1Z01VT1lhTG95M25LUFJlb2lFaUNnVHlETnRTaFpITWUwQk5GVU5PLUdQR29XVXVWNE5yc1lRbFlGVHRBa0FrT3o3eEk?oc=5" target="_blank">After 100 weeks, AC Immune's Parkinson's trial met its main safety and immune-response goals.</a>  <font color="#6f6f6f">Stock Titan</font>

Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson’s disease
Naturegeneral

Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1zbmNPT2hQUjMwdmoyOEp6elNFeXh3Y0tTU3hNLUhxMjFGQm9lVnJwbFFwRXFPbGRXckVLTnpLbVFtTXRzMVAyM2Y0VDhyNTlWZWo4cGd4SFFXZjNGaUdv?oc=5" target="_blank">Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson’s disease</a>  <font color="#6f6f6f">Nature</font>

Real-Time Quaking-Induced Conversion CSF Analysis Useful in Detecting Misfolded Alpha-Synuclein
NeurologyLivegeneral

Real-Time Quaking-Induced Conversion CSF Analysis Useful in Detecting Misfolded Alpha-Synuclein

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQWFN2RUtpY2NQOHRZbzlhQ2lZaU9SOWNIeGd2NWU1QXhCV0Rrdi1RSHlmcEZncjBaR0ZFNDdWMEJSdTQzdFRrZ0kyelQ4RzRJUExNQmJuS1ZtVFVMOXZybGNVTWVwbnVPUUdLd3pWSC1nVzd4VnNJR0hLRzJUS29ocVhENmRpU0RNc3NTb2ZPYVl3OWJtLTREMkRLRjhQcDJ3U0F1VEpXUUJUZ3FqV3JXdWc3Y2dtc3VPRHRUVHdvVXd4Ym9KM0E?oc=5" target="_blank">Real-Time Quaking-Induced Conversion CSF Analysis Useful in Detecting Misfolded Alpha-Synuclein</a>  <font color="#6f6f6f">NeurologyLive</font>

Emerging biomarkers for Parkinson's disease in biological fluids
Frontiersgeneral

Emerging biomarkers for Parkinson's disease in biological fluids

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPWDcwRUY5Yi1YbnRNRzd0QXlGVWRHcjFJWFBVX3hpRWVWMjV1RXJYOVAtMjN4ejBPZmt0cDdUNk4wZnFFeUdFSG9Ibjk5Z3BXQ1JOVElKeGttY3g5ZGRWRDRZaF9GVlNlYXMzTE0wbkRqMmk4ZXM2TG96WWxTQ3pnNFpXNEVvWWZ6NXRyR081WEl4Sy1zbVBjTVZLZks?oc=5" target="_blank">Emerging biomarkers for Parkinson's disease in biological fluids</a>  <font color="#6f6f6f">Frontiers</font>

FDA Letter Supports Amprion’s Revolutionary α-Synuclein Test
The Clinical Trial Vanguardgeneral

FDA Letter Supports Amprion’s Revolutionary α-Synuclein Test

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxQNU1ONlFJQ01kb1p3V2ZIWlRFQUdtWmxlWDVVdV9tODVTWEdlZGFnOG96d3Vwa292emkyZ3ZLYzUxVnBHQ2JHOGxGcVplRXZQQk1wT1JUNlV0c0JQaXNOdjE4SjJNQ1ZRYWI2LVFrVlR6U0d3TGV0UU1hSFhSMUxoMDAwYWJ0cEljV2NqZVBrR1Q3WDA1ZmdxVG42YTZVcmRWWDZlcUwzUXgtbDNF?oc=5" target="_blank">FDA Letter Supports Amprion’s Revolutionary α-Synuclein Test</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson’s disease
Naturegeneral

Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1IcHFjaEZOWUYzbmhpQ3liQVNrOTRYRm5OSGVmM1kzazl4eGdEeTRxTkx2WU1NQkJxOGxSdlNvVnl1eld2YlJ4SUlrdjhOWWtfUktsZ0F1U00wczBQcWI0?oc=5" target="_blank">Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson’s disease</a>  <font color="#6f6f6f">Nature</font>

Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism
Naturetech

Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBrY3JZUFprZWV2MHJHQ0pXQXUxVXZ6Sy1oZDZrdUhSV1FFdzA3MzFKbzg1b0VJZy1IVWp0YU44UTdkQlNQZl9MV2VTVnh1dDhmRlJFck84WGJ1MnhaSEZn?oc=5" target="_blank">Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism</a>  <font color="#6f6f6f">Nature</font>

A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
Naturegeneral

A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE54cTZPVms4dlhDQWNHQkJMXzJTOTRKUDJkU3EyUEt3NFlhQ19xOHRYSE1QOGhTVUpNNW1oMEZMVUt2SXAzSjlMcHVLaGRCcWt1amxJR2tiTVBpekYwQVhz?oc=5" target="_blank">A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease</a>  <font color="#6f6f6f">Nature</font>

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
Naturegeneral

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fOVkzSUV0Nm96SmN2bW1pTmhPcnQ1TFdBaHVyYzhPN2JNU0lucUVFbmlPMGRCX216OWZGbzBfSnhFS3RLT3EtbDFFQWpRT0tWMjhOcDZPamFBVE5CYzBv?oc=5" target="_blank">Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders</a>  <font color="#6f6f6f">Nature</font>

Predicting Parkinson’s disease and its progression based on radiomics in T1-weight images and α‑synuclein in cerebrospinal fluid
Naturegeneral

Predicting Parkinson’s disease and its progression based on radiomics in T1-weight images and α‑synuclein in cerebrospinal fluid

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4ybmZTRHpjU1ZSTmE3ZUFxOGhJbi11ZEd3OWxFLVpQb0ZnQ2RYRE11YkFTeVhQaEhjdVlDTlQ1dlVDa3I0SVhXMnN5WHBuOFFublFNM0dqdEFoWm91WWF3?oc=5" target="_blank">Predicting Parkinson’s disease and its progression based on radiomics in T1-weight images and α‑synuclein in cerebrospinal fluid</a>  <font color="#6f6f6f">Nature</font>

Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification
Natureworld

Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE00UDVobUxGY3ZqbUtxSmRkUi0ycGYxbFh1ZVp0dXBMaHRsczdmTFByM21WYko3SkthWTlPOGhSNURxQlBoVmRhT0otZUhfQ2FrOHFkZ3p4RnU4WEZWR2ZR?oc=5" target="_blank">Two-step detection of Lewy body pathology via smell-function testing and CSF α-synuclein seed amplification</a>  <font color="#6f6f6f">Nature</font>

Age at onset of Parkinson’s disease modulates the sphingolipid-dopaminergic interplay in autonomic progression
Naturegeneral

Age at onset of Parkinson’s disease modulates the sphingolipid-dopaminergic interplay in autonomic progression

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE13QjBVRnVyUHVXVmhBUzNWWmY5VUlQeUdBSnYzNUlRYm9oRDRuc1RDRkNMTk1NWnFlRTVLTzBUMW1OZnJtcTBqWWx0Q3ltVWROcDM2U1BtVWxhbXphUERN?oc=5" target="_blank">Age at onset of Parkinson’s disease modulates the sphingolipid-dopaminergic interplay in autonomic progression</a>  <font color="#6f6f6f">Nature</font>

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease
Naturegeneral

CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9yNjMySDFNNFExVURrSTB5Z3dlRWR6UE83eTZEQ19vbUN2Y2xxNWxQMVJzQW5XTFQ5eUJHVEZBRE1rcVNTWDM3SG5VSUNCb0g5ZVZPcFY4NjR3eXNZUW5Z?oc=5" target="_blank">CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease</a>  <font color="#6f6f6f">Nature</font>

CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
Naturegeneral

CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9xTnlZcmVVa3Z0X19BSVMzSWcweGxIWnExb1dINWh2OW42cUZRZ196X2ZnUWVRWmFDZEI1dW5ld0NfdHhYbU1ZaV9LZlN1Q1NCNW9oM3BIRHpmYkJDVTYw?oc=5" target="_blank">CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease</a>  <font color="#6f6f6f">Nature</font>

Temporal trajectory of biofluid markers in Parkinson’s disease - Scientific Reports
Naturegeneral

Temporal trajectory of biofluid markers in Parkinson’s disease - Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBLVGhWUXBxVkMxLU1TRFlhLVhnenNTNWlGa24xVjl6TEhkcThVWkJhWERHOVVoNk1LOWZLc3hMek52MEFwZDdKM1NRM1FXZWJWQU12aU9kMFBuVjlJb1pF?oc=5" target="_blank">Temporal trajectory of biofluid markers in Parkinson’s disease - Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases | Scientific Reports
Naturegeneral

Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0OFlvT3E0dkgzajQxNVlYeU14dTBCZ0xtMjVnM2QzS1hEZ2h0RUYzNU4zYkluU0xld3NyMTIwMy1YcmlLUFR6d0d5NU0wcEpSV1ZQVkludnpscTVuU2pz?oc=5" target="_blank">Alpha-synuclein is increased in erythrocytes in parkinson’s disease cases | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants
Naturegeneral

Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9TX1ZoSEZrejZFX1paeVgyamRDSEVlTXNRVjl6R0FyMlJjbm95bDdEZzZMUEpmNGRpWFlybkdTUU1lYkZMcVhhQUJGU29weHhZQ3NzanJFOE4xRElvWUpR?oc=5" target="_blank">Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants</a>  <font color="#6f6f6f">Nature</font>

ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases
Naturegeneral

ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE96U1B2Z3R5MFZoa2lQd0xQNXFHUW5yUUo5YnpoYk9reXBVd0s4MlFLdlQ2cWlxdXY4Z3kzVmdvTDlwUklzb0J4WEg2ZUVEY09raC1ieDNiaC1sNHZXcXhN?oc=5" target="_blank">ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases</a>  <font color="#6f6f6f">Nature</font>

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding
Naturegeneral

Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBua1lmVHZQT2tKVTR2TXZ6VWJ5ZlFvMVZWWmhya0JiMGxvQ2FtSHhRSVBlZUtERHdsOFF1UlJQVml0Y2RmVm04XzhNRzQ3VU1ROUdBTDBFWmZjM2N3cHJZ?oc=5" target="_blank">Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding</a>  <font color="#6f6f6f">Nature</font>

A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD | npj Parkinson's Disease
Naturegeneral

A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD | npj Parkinson's Disease

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9EZVZYME1rZFRWVnNoelhDQmtDMF9OM1hfRWk2NWVIMlZrZmR3NDJrXzJPZkxLX2hHMk1SNFdWeUNnT1pZdUdtbjFLczcwUXFUeXJFMVVFaWhGM0lqNkFz?oc=5" target="_blank">A comparative blind study between skin biopsy and seed amplification assay to disclose pathological α-synuclein in RBD | npj Parkinson's Disease</a>  <font color="#6f6f6f">Nature</font>

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease
Naturegeneral

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFA5SE1abVM1WTBLV3dndko2akUzOW9ENG55UjBhZGtHc0FIWFM3dFI5cDY4QnZvRzdTSG9HOEhIdXdIZC1hRWxseVowcDVNS19zMFdv?oc=5" target="_blank">Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease</a>  <font color="#6f6f6f">Nature</font>

α-Synuclein Seeding Amplification Assay: A Breakthrough in Diagnosing Parkinson Disease?
Journal of Nuclear Medicinegeneral

α-Synuclein Seeding Amplification Assay: A Breakthrough in Diagnosing Parkinson Disease?

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE9RWVVUNlJvb0pvNkVfTURfLXlSYi0tSW5SNE5uWm1OTVdfS2pzdURpcWF0d3hWQWx2cWJ2aDZpVEpGTUUzaFhPMnJ0NzdWdE8xOXRxS0pRcw?oc=5" target="_blank">α-Synuclein Seeding Amplification Assay: A Breakthrough in Diagnosing Parkinson Disease?</a>  <font color="#6f6f6f">Journal of Nuclear Medicine</font>

UB-312 Reduces α-Synuclein in Parkinson Disease in Phase 1 Trial
NeurologyLivegeneral

UB-312 Reduces α-Synuclein in Parkinson Disease in Phase 1 Trial

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPcUl2VVF0VXVEVkxXR1RxS2hBQkdSMXVMQXc3UFNrZGV0YVhGem15eGRtYXpwby01STgwU1BNbFVnUXBHdWgtY3I0U241Z1NzS2lyTHBRalhwNFdYdkdrUVVSM2dKeFQ2dWdyY3hKQ1ZKMjZVVTF4VUh3WDg0TDdtUEVEcXN0MlU2cGc?oc=5" target="_blank">UB-312 Reduces α-Synuclein in Parkinson Disease in Phase 1 Trial</a>  <font color="#6f6f6f">NeurologyLive</font>

Cognitive effects of Lewy body pathology in clinically unimpaired individuals
Naturetech

Cognitive effects of Lewy body pathology in clinically unimpaired individuals

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1Oc3h6eHpPbFBST3hKbEZaNjVPQnV4bjRZR05xWUtnVmE2Nzd1cUUzZmtWWm91a0xkallfZHllM0lXQmRZNlhmNGZwQmlPX2lQS3A2OHVTYnc3eEZZZ0Nj?oc=5" target="_blank">Cognitive effects of Lewy body pathology in clinically unimpaired individuals</a>  <font color="#6f6f6f">Nature</font>

AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson’s disease diagnosis
Springer Nature Linkgeneral

AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson’s disease diagnosis

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1NcTlHVVQxVjM4YXV0b1FYazY2MVVIZ1dyY1hJem1oRF9Ma0ZSRVhHWTJtOEh1RUpDVzZ5RU5oMkk5ZWFMcGdCRmUtaFBGQWFUMTBWQVM3bXZzQ2dvLVpPbFFGUUIyMS1keWs0?oc=5" target="_blank">AlphaLISA detection of alpha-synuclein in the cerebrospinal fluid and its potential application in Parkinson’s disease diagnosis</a>  <font color="#6f6f6f">Springer Nature Link</font>

Clinical effects of Lewy body pathology in cognitively impaired individuals
Naturetech

Clinical effects of Lewy body pathology in cognitively impaired individuals

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBSX0ZZLWFrYXhZYjFEZzBEVHhXTk5nTmVwa2FYVEVHbURXWjJkdlo5cVVqeThMdGo1SGkwUGl1TUJSNXdUOTdCLTR0T1g5dUFMWUhEOGlTSFdBS0w4ZjVZ?oc=5" target="_blank">Clinical effects of Lewy body pathology in cognitively impaired individuals</a>  <font color="#6f6f6f">Nature</font>

Lessons Learned in Time—Is Neurodegeneration Still Something Unpredictable?
Springer Nature Linkworld

Lessons Learned in Time—Is Neurodegeneration Still Something Unpredictable?

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE96cEpMQkZ5ZkREMEdhRnJQcUJ1YmhFbHRubVVZQVFQMHlpZk5lRUV3aUo4bEtkSzdYRnkyUFJnRlNKZlphM3IzQnh3Y2ROY203Yll3cFBLbTdCZl8tWV9ZaGN2WE1iWDRVYkxKVQ?oc=5" target="_blank">Lessons Learned in Time—Is Neurodegeneration Still Something Unpredictable?</a>  <font color="#6f6f6f">Springer Nature Link</font>

"A cerebrospinal fluid syn" — Live Google News Trends & Headlines